Presentation of Lipid Antigens by CD1 Glycoproteins

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|28|3311-3317

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.28, 2009-10, pp. : 3311-3317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Tumor-Associated Antigens to the MHC Class I Presentation Pathway

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 2, 2007-06 ,pp. : 99-109

Bentham Science Publishers

Access to resources Recommend Favorite

Rational Modifications of HIV-1 Envelope Glycoproteins for Immunogen Design

By  

Current Pharmaceutical Design, Vol. 13, Iss. 2, 2007-01 ,pp. : 213-227

Bentham Science Publishers

Access to resources Recommend Favorite

Biphasic Lipid Vesicles as a Subcutaneous Delivery System for Protein Antigens and CpG Oligonucleotides

By  

Current Drug Delivery, Vol. 3, Iss. 2, 2006-04 ,pp. : 129-135

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Drug Targets on the HIV-1 Envelope Glycoproteins, gp120 and gp41

By  

Current Pharmaceutical Design, Vol. 9, Iss. 18, 2003-07 ,pp. : 1453-1462

Bentham Science Publishers

Access to resources Recommend Favorite

Pregnancy-Specific β1-Glycoproteins: Combined Biomarker Roles, Structure/Function Relationships and Implications for Drug Design

By  

Current Medicinal Chemistry, Vol. 24, Iss. 3, 2017-02 ,pp. : 245-267

Bentham Science Publishers

Access to resources Recommend Favorite